AMAG PHARMACEUTICALS INC. 4
4 · AMAG PHARMACEUTICALS INC. · Filed Feb 26, 2014
Insider Transaction Report
Form 4
White Christopher G
Chief Business Officer and SVP
Transactions
- Sale
Common Stock
2014-02-26$21.58/sh−400$8,632→ 24,000 total - Sale
Common Stock
2014-02-25$21.71/sh−434$9,422→ 24,400 total
Footnotes (1)
- [F1]The shares reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.